Notice2026-07880
Tiered Pharmacy Copayments for Medications; Calendar Year 2026 Update
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
April 23, 2026
Issuing agencies
Veterans Affairs Department
Abstract
This Department of Veterans Affairs (VA) Notice updates the information on Tier 1 Medications.
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 78 (Thursday, April 23, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 78 (Thursday, April 23, 2026)]
[Notices]
[Pages 21874-21875]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-07880]
-----------------------------------------------------------------------
DEPARTMENT OF VETERANS AFFAIRS
[Docket No. VA-2026-VACO-0001]
Tiered Pharmacy Copayments for Medications; Calendar Year 2026
Update
AGENCY: Department of Veterans Affairs.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This Department of Veterans Affairs (VA) Notice updates the
information on Tier 1 Medications.
FOR FURTHER INFORMATION CONTACT: Tamara Wagner, Management Analyst,
Office of Finance/Revenue Operations, Veterans Health Administration,
(970) 242-0731, extension 2219.
SUPPLEMENTARY INFORMATION: Section 17.110 of title 38, Code of Federal
Regulations (CFR), governs copayments for medications that VA provides
to veterans. Section 17.110 provides the methodologies for establishing
the copayment amount for each 30-day or less supply of medication
provided by VA on an outpatient basis (other than medication
administered during treatment).
Tier 1 medication means a multi-source medication that has been
identified using the process described in paragraph (b)(2) of Sec.
17.110. Not less than once per year, VA will identify a subset of
multi-source medications as Tier 1 medications. Only medications that
meet all the criteria in 38 CFR 17.110(b)(2)(i), (ii), and (iii) will
be eligible to be considered Tier 1 medications, and only those
medications that meet all the criteria in paragraph (b)(2)(i) of this
section will be assessed using the criteria in paragraphs (b)(2)(ii)
and (iii).
Based on the methodologies set forth in Sec. 17.110, this notice
updates the list of Tier 1 medications for Calendar Year 2026. The Tier
1 medication list is posted on VA's website at the following link:
<a href="http://www.va.gov/resources/va-tier-1-copay-medication-list">www.va.gov/resources/va-tier-1-copay-medication-list</a>.
The following table is the Tier 1 Copay Medication List that is
effective January 1, 2026, and will remain in effect until December 31,
2026.
------------------------------------------------------------------------
Condition VA product name
------------------------------------------------------------------------
Arthritis and Pain................ Aspirin buffered tablet, Aspirin
chewable tablet, Aspirin enteric
coated tablet, Allopurinol tablet,
Celecoxib capsule, Diclofenac
tablet, Ibuprofen tablet, Meloxicam
tablet, Naproxen tablet.
Blood Thinners and Platelet Clopidogrel Bisulfate tablet.
Inhibitors.
Cholesterol....................... Atorvastatin tablet, Ezetimibe
tablet, Fenofibrate capsule or
tablet, Pravastatin tablet,
Rosuvastatin Calcium (CA) tablet,
Simvastatin tablet.
Dementia.......................... Donepezil tablet.
Diabetes.......................... Glipizide tablet, Metformin
Hydrochloride (HCL) tablet,
Metformin HCL 24-hour Sustained
Action (SA) tablet, Pioglitazone
HCL tablet.
Electrolyte Supplement............ Potassium SA tablet, Potassium SA
dispersible tablet.
Gastrointestinal Health........... Famotidine tablet, Omeprazole
Enteric-Coated (EC) capsule,
Pantoprazole Sodium capsule,
Psyllium (regular and sugar-free)
bulk powder.
Glaucoma and Eye Care............. Carboxymethylcellulose Sodium
Ophthalmic Solution, Brimonidine
0.2% ophthalmic solution,
Diclofenac ophthalmic solution,
Latanoprost (excludes preservative-
free) 0.005% Ophthalmic solution,
Polyethylene Glycol Ophthalmic
solution.
Heart Health and Blood Pressure... Amiodarone tablet, Amlodipine
tablet, Aspirin (see Arthritis &
Pain), Atenolol tablet, Carvedilol
tablet, Chlorthalidone tablet,
Clonidine tablet, Diltiazem 24-hour
capsule, Diltiazem HCL tablet,
Furosemide tablet, Hydralazine HCL
tablet, Hydrochlorothiazide tablet/
capsule, Hydrochlorothiazide/
Lisinopril tablet,
Hydrochlorothiazide/Triamterene tab/
cap, Isosorbide Mononitrate SA
tablet, Lisinopril tablet, Losartan
tablet, Metoprolol Succinate SA
tablet, Metoprolol Tartrate tablet,
Nifedipine SA capsule,
Nitroglycerin sublingual tablet,
Prazosin HCL capsule,
Spironolactone tablet, Valsartan
tablet.
Hormones/Other.................... None.
Mental Health..................... Amitriptyline HCL tablet, Buspirone
HCL tablet, Bupropion HCL tablet,
Bupropion HCL SA (12 hour-SR)
tablet, Bupropion HCL SA (24 hour-
XL) tablet, Citalopram Hydrobromide
tablet, Duloxetine HCL EC capsule,
Escitalopram Oxalate tablet,
Fluoxetine tablet/capsule,
Memantine tablet, Mirtazapine
tablet, Paroxetine tablet,
Quetiapine Immediate release (IR)
Tablet, Sertraline HCL tablet,
Trazodone tablet, Venlafaxine HCL
IR tablet, Venlafaxine HCL SA
capsule.
Neurologic Disorders.............. Ropinirole tablet.
Respiratory Condition............. Montelukast Sodium tablet.
Seizures.......................... Gabapentin capsule, Lamotrigine
tablet, Topiramate tablet.
Thyroid Conditions................ Levothyroxine Sodium tablet.
[[Page 21875]]
Urologic (Bladder and Prostate) Doxazosin Mesylate tablet,
Health. Finasteride tablet, Oxybutynin
Chloride SA tablet, Sildenafil
tablet, Tadalafil tablet,
Tamsulosin HCL capsule, Terazosin
HCL capsule.
------------------------------------------------------------------------
(Authority: 38 U.S.C. 501; 38 CFR 17.110(b)(3))
Signing Authority: Douglas A. Collins, Secretary of Veterans
Affairs, approved this document on April 16, 2026, and authorized the
undersigned to sign and submit the document to the Office of the
Federal Register for publication electronically as an official document
of the Department of Veterans Affairs.
Gabriela DeCuir,
Alternate Federal Register Liaison Officer, Department of Veterans
Affairs.
[FR Doc. 2026-07880 Filed 4-22-26; 8:45 am]
BILLING CODE 8320-01-P
</pre></body>
</html>Indexed from Federal Register on April 23, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.